Sort
8,912 grants matching “sars cov 2”
Viral Testing Core
$30,808Smriti Mehra · Texas Biomedical Research Institute · U42 · FY2024 · OD
Single Molecule Biophysics of Intrinsically Disordered Proteins in Disease
$30,752Jhullian Jamille Alston · Washington University · F99 · FY2022 · CA
Developing research training in Zambia to address the epidemic of cardiovascular disease and mental illness amongst HIV infected populations.
$30,467Carolyn Bolton Moore · Centre For Infectious Disease Research · D71 · FY2022 · TW
Atherogenic mechanisms of SVEP1, a Novel Human Coronary Artery Disease Locus
$30,321Jared Scott Elenbaas · Washington University · F30 · FY2021 · HL
Molecular Characterization of the SARS-CoV-2 Helicase and High-Throughput Screening to Identify Small Molecule SARS-CoV-2 Helicase Inhibitors as Anti-Viral Medicines
$30,287Robert Brosh · National Institute On Aging · ZIA · FY2020 · AG
Dissecting the role of the coronavirus proofreading exoribonuclease in RNA recombination
$30,260Jennifer Gribble · Vanderbilt University · F31 · FY2020 · AI
Rapid Generation of Vaccine Candidates Against Novel Coronavirus (SARS-CoV-2) Using the Bacteriophage T4 Nanoparticle Platform
$30,170Richard J. Kuhn · Purdue University · R01 · FY2021 · AI
In Vivo Cluster AI Prediction (CLAIRE) of COVID-19 Disease Progression
$30,166Patricia Buendia · Lifetime Omics, Inc. · R43 · FY2022 · EB
AADOCR Bloc Travel Grant
$30,000Christopher H Fox · American Association For Dental, Oral, And Craniofacial Research · R13 · FY2024 · DE
HIV-DART 2024
$30,000Raymond F. Schinazi · Emory University · R13 · FY2025 · AI
AADOCR Bloc Travel Grant
$30,000Christopher H Fox · American Association For Dental, Oral, And Craniofacial Research · R13 · FY2023 · DE
SARS-CoV-2 Immunology and Therapeutics
$29,973Kim Hasenkrug · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Roles of replication fidelity in viral RNA synthesis, population diversity, and overall fitness of coronaviruses
$29,684Kevin Whittle Graepel · Vanderbilt University · F30 · FY2019 · AI
Impact of the COVID-19 Pandemic on Alcohol Use and Outcomes: The Role of Health Disparities
$29,652Courtney Lynn Vaughan · Henry M. Jackson Fdn For The Adv Mil/Med · F31 · FY2022 · AA
Inducible HMGB1 antagonist for viral-induced acute lung injury.
$29,640Jorge C Blanco · Sigmovir Biosystems, Inc. · R41 · FY2024 · HL
The Impact of SARS-CoV-2 Infection and Vaccination on the Risk of Alzheimerâs Disease and Related Dementias
$29,540Jingxuan Wang · University Of California, San Francisco · F99 · FY2025 · AG
Boston OAIC: A Translational Approach to Function Promoting Therapies
$29,228Shalendar Bhasin · Brigham And Women'S Hospital · P30 · FY2022 · AG
Coronavirus antiviral nucleoside analogs: inhibition and reduced susceptibility
$29,206Maria Agostini · Vanderbilt University · F31 · FY2018 · AI
Roles of replication fidelity in viral RNA synthesis, population diversity, and overall fitness of coronaviruses
$29,192Kevin Whittle Graepel · Vanderbilt University · F30 · FY2018 · AI
Placental origins of phthalate-induced changes in fetal reproductive development
$29,057Jennifer Joan Adibi · University Of Pittsburgh At Pittsburgh · R01 · FY2022 · ES
Therapeutic Monoclonal Antibodies Inhibiting Proteases of Biomedical Importance
$28,988Xin Ge · University Of Texas Hlth Sci Ctr Houston · R35 · FY2024 · GM
Urinary Exosomes and COVID-19
$28,951Mark Knepper · National Heart, Lung, And Blood Institute · ZIA · FY2022 · HL
Coronavirus antiviral nucleoside analogs: inhibition and reduced susceptibility
$28,726Maria Agostini · Vanderbilt University · F31 · FY2017 · AI
Roles of replication fidelity in viral RNA synthesis, population diversity, and overall fitness of coronaviruses
$28,712Kevin Whittle Graepel · Vanderbilt University · F30 · FY2017 · AI
Assessing the efficacy of BCG vaccination in a pre-clinical model of SARS-CoV-2 infection
$28,644Alan Sher · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI